ATE333451T1 - Verwendung von nitrilenverbindungen als arztneimittel - Google Patents
Verwendung von nitrilenverbindungen als arztneimittelInfo
- Publication number
- ATE333451T1 ATE333451T1 AT03761003T AT03761003T ATE333451T1 AT E333451 T1 ATE333451 T1 AT E333451T1 AT 03761003 T AT03761003 T AT 03761003T AT 03761003 T AT03761003 T AT 03761003T AT E333451 T1 ATE333451 T1 AT E333451T1
- Authority
- AT
- Austria
- Prior art keywords
- medicinal products
- nitrile compounds
- compounds
- diseases associated
- inhibitors
- Prior art date
Links
- -1 NITRILE COMPOUNDS Chemical class 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 108010005843 Cysteine Proteases Proteins 0.000 abstract 2
- 102000005927 Cysteine Proteases Human genes 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 108090000613 Cathepsin S Proteins 0.000 abstract 1
- 102100035654 Cathepsin S Human genes 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002441 reversible effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0201977A SE0201977D0 (sv) | 2002-06-24 | 2002-06-24 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE333451T1 true ATE333451T1 (de) | 2006-08-15 |
Family
ID=20288335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03761003T ATE333451T1 (de) | 2002-06-24 | 2003-06-23 | Verwendung von nitrilenverbindungen als arztneimittel |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20050245522A1 (de) |
| EP (1) | EP1532124B1 (de) |
| JP (1) | JP2005533805A (de) |
| AT (1) | ATE333451T1 (de) |
| AU (1) | AU2003243097A1 (de) |
| CY (1) | CY1107342T1 (de) |
| DE (1) | DE60306934T2 (de) |
| DK (1) | DK1532124T3 (de) |
| ES (1) | ES2268423T3 (de) |
| PT (1) | PT1532124E (de) |
| SE (1) | SE0201977D0 (de) |
| WO (1) | WO2004000825A1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0201977D0 (sv) * | 2002-06-24 | 2002-06-24 | Astrazeneca Ab | Novel compounds |
| EP2112920B1 (de) | 2003-06-26 | 2018-07-25 | Intellipharmaceutics Corp. | Protonenpumpeninhibitoren enthaltende kapseln, die verschieden aufgebaute untereinheiten zur verzögerten wirkstofffreisetzung enthalten |
| WO2005000800A1 (en) * | 2003-06-30 | 2005-01-06 | Merck Frosst Canada Ltd. | Cathepsin cysteine protease inhibitors |
| US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
| US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
| US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
| WO2007095140A2 (en) | 2006-02-11 | 2007-08-23 | Genetronics, Inc. | Device and method for single-needle in vivo electroporation |
| WO2007112581A1 (en) | 2006-04-03 | 2007-10-11 | Isa Odidi | Controlled release delivery device comprising an organosol coat |
| US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
| US20090118274A1 (en) * | 2007-02-15 | 2009-05-07 | Darin Allen | Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| US20080207683A1 (en) * | 2007-02-15 | 2008-08-28 | Darin Allen | Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| US20090099157A1 (en) * | 2007-02-15 | 2009-04-16 | Ameriks Michael K | Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s |
| US20080200454A1 (en) * | 2007-02-15 | 2008-08-21 | Ameriks Michael K | Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| US20080269241A1 (en) * | 2007-02-15 | 2008-10-30 | Darin Allen | Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| AU2008269513B2 (en) * | 2007-06-26 | 2011-06-16 | Astrazeneca Ab | 1-cyanocyclopropyl-derivatives as cathepsin K inhibitors |
| WO2009001128A1 (en) * | 2007-06-26 | 2008-12-31 | Astrazeneca Ab | 1,2-cycl0hexane dicarboxamides as cathepsin inhibitors |
| WO2009001127A1 (en) * | 2007-06-26 | 2008-12-31 | Astrazeneca Ab | Cyanocyclopropylcarboxamides as cathepsin inhibitors |
| US7893099B2 (en) | 2009-06-11 | 2011-02-22 | Hoffman-La Roche Inc. | Cyclopentane derivatives |
| EP2450755B1 (de) * | 2010-11-04 | 2015-01-21 | Nivarox-FAR S.A. | Synchronhemmung für Uhrwerk |
| WO2020201572A1 (en) | 2019-04-05 | 2020-10-08 | Université De Bretagne Occidentale | Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1161415B1 (de) * | 1999-03-15 | 2005-07-13 | Axys Pharmaceuticals, Inc. | N-cyanomethylamide als protease inhibitoren |
| WO2001009110A1 (en) * | 1999-07-30 | 2001-02-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | Novel succinate derivative compounds useful as cysteine protease inhibitors |
| US20010041700A1 (en) * | 1999-07-30 | 2001-11-15 | Younes Bekkali | Novel succinate derivative compounds useful as cysteine protease inhibitors |
| SE0201977D0 (sv) * | 2002-06-24 | 2002-06-24 | Astrazeneca Ab | Novel compounds |
-
2002
- 2002-06-24 SE SE0201977A patent/SE0201977D0/xx unknown
-
2003
- 2003-06-23 DE DE60306934T patent/DE60306934T2/de not_active Expired - Lifetime
- 2003-06-23 WO PCT/SE2003/001080 patent/WO2004000825A1/en not_active Ceased
- 2003-06-23 EP EP03761003A patent/EP1532124B1/de not_active Expired - Lifetime
- 2003-06-23 US US10/518,818 patent/US20050245522A1/en not_active Abandoned
- 2003-06-23 PT PT03761003T patent/PT1532124E/pt unknown
- 2003-06-23 AT AT03761003T patent/ATE333451T1/de not_active IP Right Cessation
- 2003-06-23 AU AU2003243097A patent/AU2003243097A1/en not_active Abandoned
- 2003-06-23 ES ES03761003T patent/ES2268423T3/es not_active Expired - Lifetime
- 2003-06-23 JP JP2004515330A patent/JP2005533805A/ja active Pending
- 2003-06-23 DK DK03761003T patent/DK1532124T3/da active
-
2006
- 2006-10-13 CY CY20061101476T patent/CY1107342T1/el unknown
-
2008
- 2008-06-03 US US12/132,080 patent/US20080234274A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003243097A1 (en) | 2004-01-06 |
| CY1107342T1 (el) | 2012-12-19 |
| US20080234274A1 (en) | 2008-09-25 |
| SE0201977D0 (sv) | 2002-06-24 |
| ES2268423T3 (es) | 2007-03-16 |
| DK1532124T3 (da) | 2006-10-30 |
| DE60306934T2 (de) | 2007-02-15 |
| PT1532124E (pt) | 2006-11-30 |
| US20050245522A1 (en) | 2005-11-03 |
| WO2004000825A1 (en) | 2003-12-31 |
| DE60306934D1 (de) | 2006-08-31 |
| EP1532124B1 (de) | 2006-07-19 |
| EP1532124A1 (de) | 2005-05-25 |
| JP2005533805A (ja) | 2005-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0201980D0 (sv) | Novel compounds | |
| ATE333451T1 (de) | Verwendung von nitrilenverbindungen als arztneimittel | |
| SE0201976D0 (sv) | Novel compounds | |
| ATE387197T1 (de) | Cyanoalkylamino-derivate als protease-hemmer | |
| IS7925A (is) | Hýdroxýetýlamínafleiður til að meðhöndla Alzheimers-sjúkdóm | |
| ATE506951T1 (de) | Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit | |
| ATE447574T1 (de) | 3-amino-4-phenylbutansäurederivate als dipeptidylpeptidase-hemmer zur behandlung oder vorbeugung von diabetes | |
| ATE483692T1 (de) | Als beta-sekretase (bace)-hemmer nützliche 2- amino-chinazolinderivate | |
| ATE513917T1 (de) | Bakterielle expression von proteaseinhibitoren und varianten davon | |
| WO2005028429A3 (en) | Haloalkyl containing compounds as cysteine protease inhibitors | |
| ATE482936T1 (de) | Als b-sekretase (bace)-hemmer nützliche 2-amino- chinazolinderivate | |
| SE0203712D0 (sv) | Novel compounds | |
| DK1539724T3 (da) | Aminobenzothiazolforbindelser med NOS-inhiberende aktivitet | |
| TW200509919A (en) | Cathepsin S inhibitors | |
| WO2005063742A3 (en) | Amidino compounds as cysteine protease inhibitors | |
| WO2005074904A3 (en) | Silinane compounds as cysteine protease inhibitors | |
| WO2006102243A3 (en) | Alpha ketoamide compounds as cysteine protease inhibitors | |
| MX2009003563A (es) | Compuestos que contienen di-fluoro como inhibidores de proteasa de cisteina. | |
| MX2007011739A (es) | Compuestos que contienen sulfonilo como inhibidores de cisteina proteasa. | |
| WO2002023784A3 (en) | Cysteine protease inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1532124 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |